Temozolomide Feasibility Calculator

for elderly patients with glioblastoma


F Putz et al. (2014)

* Probability of successful administration of concurrent chemotherapy with a cumulative dose of temozolomide >2655 mg/m

Note:
Active inflammation can cause thrombocytosis without increased tolerability of temozolomide
Female? :
Age (≥ 65 years) :
Pretreatment platelet count (10 cells/l) :
Probability* %